Legal Representation
Attorney
James E. Rosini
USPTO Deadlines
Next Deadline
309 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20201117)
Due Date
November 17, 2026
Grace Period Ends
May 17, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 17, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Nov 17, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 16, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Oct 15, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Oct 5, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 5, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 18, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 20, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 20, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 20, 2020 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Mar 6, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Feb 14, 2020 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Mar 6, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 14, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Nov 8, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Nov 8, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 3, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 9, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 9, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 19, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 4, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 22, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 22, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 22, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 22, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 22, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 25, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 25, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 25, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 15, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 22, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 2, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Providing support to the pharmaceutical, biotechnology, and medical device industries in the form of research services, namely, preclinical drug safety assessment, clinical trials associated with drug development and medical devices, bioanalysis for drug development research purposes, as well as medical and scientific research services
First Use Anywhere:
Feb 11, 2019
First Use in Commerce:
Feb 11, 2019
Classification
International Classes
042